02552nam 2200613 a 450 991080847560332120230721014041.00-19-773783-81-283-05869-397866130586900-19-971974-8(CKB)2670000000082213(EBL)886688(OCoLC)710992761(SSID)ssj0000472057(PQKBManifestationID)12165334(PQKBTitleCode)TC0000472057(PQKBWorkID)10434971(PQKB)11218107(Au-PeEL)EBL886688(CaPaEBR)ebr10460685(CaONFJC)MIL305869(MiAaPQ)EBC886688(EXLCZ)99267000000008221320060127d2007 uy 0engur|n|---|||||txtccrPharmaceutical economics and policy[electronic resource] /Stuart O. Schweitzer2nd ed.Oxford ;New York Oxford University Press20071 online resource (351 p.)Description based upon print version of record.0-19-530095-5 Includes bibliographical references and index.pt. 1. The industry -- pt. 2. The consumer -- pt. 3. The market -- pt. 4. Intervention in the pharmaceutical market : public and private.The pharmaceutical industry is praised as a world leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. At the same time, the industry is also criticized for its marketing and pricing practices and for its apparent anticompetitive responses to generic competition. Even its research and development priorities are criticized as being too closely driven by the goal of maximizing shareholder value, rather than the health of the public. Unfortunately, many of the critics of the industry fail to understand tPharmaceutical industryUnited StatesPharmaceutical policyUnited StatesPharmaceutical industryPharmaceutical industryPharmaceutical policyPharmaceutical industry.338.4/761510973Schweitzer Stuart O271328MiAaPQMiAaPQMiAaPQBOOK9910808475603321Pharmaceutical economics and policy1415504UNINA